Investigation on the development of visual fields, nerve fiber layer and retinal microcirculation in patients with glaucoma

Investigation on the development of visual fields, nerve fiber layer and retinal microcirculation in patients with glaucoma - DVA in glaucoma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009623

Enrollment

Registered

2015-11-19

Start date

2015-11-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H40

Interventions

Group 1: Standard eye drops for 6 months (e.g. Travatan (Travoprost 40 µg/ml) once daily)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: new diagnosed glaucoma

Exclusion criteria

Exclusion criteria: cerebral convulsions, untreated systemic dieseases, eye surgeries except cataract surgery, eye diseases except glaucoma, refractive errors > 3 diopters

Design outcomes

Primary

Measure	Time frame
For diagnosis and up to 6 months after initiation of a standard therapy with antiglaucomatous eye drops visual fields, the retinal nerve fiber layer, the optic nerve head, the eye pressure and the dynamic vessel analysis are measured.	—

Countries

Germany

Contacts

Public ContactStephan Kremmer

Augenklinik, Evangelisches Krankenhaus Gelsenkirchen

info@augenzentrum-gelsenkirchen.de0049 – 209 – 37261

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026